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Stent grafting for aneurysmal degeneration of
chronic descending thoracic aortic dissections
Derek P. Nathan, MD,a Edward Y. Woo, MD,b Ronald M. Fairman, MD,b Grace J. Wang, MD,b
Alberto Pochettino, MD,c Nimesh D. Desai, MD,c Joseph E. Bavaria, MD,c and
Benjamin M. Jackson, MD,b Philadelphia, Pa
Objective: The objective of this study was to examine the results of thoracic endovascular aneurysm repair (TEVAR) for
chronic descending thoracic aortic (DTA) dissections with aneurysmal degeneration.
Methods: Over 70 months at a single institution, 27 patients underwent TEVAR for aneurysms related to chronic (>6
weeks) DTA dissections.
Results:Mean patient age was 67.5 9.6 years; 18 were men. Primary indications for repair were aneurysm size (n 20),
rapid aneurysmal growth (n  5), saccular aneurysm (n  1), and rupture (n  1). Preoperative false lumen status was
patent in 18 patients, partially thrombosed in 8 patients, and unknown in the patient whose aneurysm ruptured. The
proximal entry tear was covered in all 27 patients. Fourteen patients required coverage of the left subclavian artery, of
which 9 patients underwent prophylactic revascularization. On completion angiogram, no patient had antegrade
perfusion of the aneurysmal false lumen. There were three procedural complications: 2 patients sustained paraparesis (one
resolved and one improved), and 1 patient had an access injury requiring stent graft placement. Thirty-day mortality was
3.7% (1 of 27); the one death was in the patient whose aneurysm ruptured. Of the 26 surviving patients, 23 (88.5%) had
thrombosis of the aneurysmal false lumen. Twenty-two patients (84.6%) had stability or decrease in maximal aneurysm
diameter on last radiographic follow-up at 18  20 months. Three-year Kaplan-Meier survival was 90.3%  6.5% in the
26 patients who survived to hospital discharge, with a mean follow-up of 27.3  22.1 months. In patients with
preoperatively partially thrombosed false lumens (n  8), 3-year survival was 100%.
Conclusions: TEVAR for aneurysms due to chronic dissections of the DTA can be performed safely and effectively at
midterm follow-up according to this single-institution study. Stent graft therapy may be of particular benefit in patients
presenting with partially thrombosed false lumens. (J Vasc Surg 2012;55:963-7.)
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The survival of patients with descending thoracic aortic
(DTA) dissections who survive to hospital discharge ranges
from 48% to 82% at 5 years.1-4 Aneurysmal degeneration
contributes significantly to these poor outcomes, as 20% to
40% of patients with DTA dissections develop aneurysms
requiring intervention.5,6 Open surgery for aneurysmal
degeneration of chronic dissections of the DTA has been
associated with considerable morbidity and mortality.7,8 In
light of the improved outcomes with endovascular therapy
of complicated, acute aortic dissections,9,10 several single
institutions have investigated the use of thoracic endovas-
cular aneurysm repair (TEVAR) in the setting of chronic
type B dissections; these studies have reported favorable,
intermediate outcomes.5,11
However, several questions remain regarding the appli-
cation of TEVAR to aneurysmal degeneration of chronic
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doi:10.1016/j.jvs.2011.11.003TA dissections. First, it is unclear which patients with
hronic DTA dissections might benefit from endovascular
herapy.11-13 Second, the management of chronic dissec-
ions of the DTA with respect to coverage of the entry and
e-entry tears is ill-defined.5 This study examines midterm
esults of TEVAR for aneurysmal degeneration of chronic
TA dissections in order to elucidate its utility for this
isease process. In particular, this study examines the char-
cteristics that might predict successful outcomes with en-
ovascular therapy.
ETHODS
Patients. A prospectively maintained cardiovascular
urgery database was used to retrospectively analyze data on
atients who underwent TEVAR between January 2005
nd October 2010 at the Hospital of the University of
ennsylvania. Of the 513 patients who underwent TEVAR
uring the study period at this single institution, 27 pa-
ients (5.3%) underwent TEVAR for aneurysmal degener-
tion of chronic DTA dissections. None of these 27 pa-
ients had malperfusion as the primary indication for
ntervention. Additional indications for TEVAR are re-
orted in Table I. Chronic dissection was defined as 6
eeks since the onset of symptoms and the diagnosis of the
TA dissection. Primary indications for repair included
neurysm 5.5 cm (n  20), rapid aneurysmal enlarge-
ent (5 mm over 6 months; n  5), saccular aneurysm
2 cm (n  1), and rupture (n  1). This study was
onducted with the approval of the center’s Human Re-
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sent from the patients was waived.
Procedures. Intravascular ultrasound scan was used
selectively (n  10) to verify true lumen access, as was
cerebrospinal fluid drainage (n  12), which was used
based on the planned extent of aortic coverage and previous
aortic surgery. Monitoring of spinal cord function with
somatosensory-evoked potentials and cerebral perfusion
with electroencephalogram were used in all elective cases,
and in nonelective cases when available. The Gore TAG
endografts (W. L. Gore and Associates, Flagstaff, Ariz)
were used in 21 patients, the Zenith TX2 endografts (Cook
Medical Incorporated, Bloomington, Ind) were used in
three patients, and the Medtronic Talent endografts
(Medtronic, Santa Rosa, Calif) were used in three patients.
Device sizing was performed according to the primary goal
of sealing the primary entry tear; the aorta is generally
undissected proximal to this tear, so device sizing was done
according to the appropriate device instructions for use.
Statistical analysis. Primary outcome variables were
midterm outcomes and procedural outcomes. Procedural
outcomes included 30-day mortality and major complica-
tions. Midterm outcomes included 3-year survival and sta-
tus of the aneurysmal false lumen on last radiographic
follow-up. Aneurysm sac enlargement (5 mm), regres-
sion (5 mm), and stability (no significant change in sac
diameter) were defined according to the Society for Vascu-
lar Surgery reporting standards.14 Typically, patients un-
derwent computed tomographic angiography at 1 month,
6 months, and 1 year postprocedure, and then annually.
Disease-related (dissection extent above or below dia-
phragm, interval between dissection, diagnosis, and treat-
ment, history of ascending aortic dissection repair, preop-
erative false lumen status, and number of visceral and renal
vessels perfused by the true lumen) and treatment-related
(left subclavian artery coverage and extent of aortic cover-
age) variables were assessed for their influence on the
primary outcomes using Pearson 2 test, t test, and Mann-
Whitney U test, as appropriate. Patient follow-up informa-
tion was collected through the interrogation of medical
Table I. Indications for TEVAR at the Hospital of the
University of Pennsylvania
Indication N (%)
Bland aneurysmal disease 281 (54.8)
Complicated acute aortic syndrome
(aortic dissection, intramural
hematoma, or penetrating
atherosclerotic ulcer) 87 (17.0)
Prophylactic antegrade placement
during type A dissection repair 53 (10.3)
Traumatic aortic dissection 31 (6.0)
Chronic type B dissection with
aneurysmal degeneration 27 (5.3)
Other 34 (6.6)
TEVAR, Thoracic endovascular aneurysm repair.records, the Social Security Database Index, and telephone hnterviews. Long-term survival was determined with the
aplan-Meier life-table methods. Log rank tests were used
o compare life-table curves for categorical variables. Cox
roportional hazards were also used to evaluate the effects
f continuous variables on long-term mortality. Statistical
nalyses were performed with SPSS software (SPSS, Chi-
ago, Ill). Data are presented in mean  SD.
ESULTS
Patient and dissection characteristics. Themean age
f the patients was 67.5  9.6 years. The interval from
iagnosis of aortic dissection to TEVAR was 47.0  44.2
onths. Nine patients (33.3%) had previous type A dissec-
ion repairs; of those, three patients (11.1%) had previous
otal arch replacements. Patient demographics are pre-
ented in Table II.
The mean maximum DTA aneurysm diameter was
.1  1.1 cm. The preoperative false lumen status of the
atients was patent in 18 patients and partially thrombosed
n eight patients (Fig 1). The false lumen status of the
atient with the rupture was unknown.
Ten patients (37.0%) had Debakey extent IIIa dissec-
ions. Of the 17 patients with extent IIIb dissections, seven
ad all four renal and visceral vessels perfused by the true
umen, seven had three vessels perfused by the true lumen,
nd three had two vessels perfused by the true lumen. The
eft renal artery was the vessel most commonly supplied by
he false lumen (n  7).
Operative details. Three patients (11.1%) required
ccess of the right common iliac artery through a retroper-
toneal incision due to inadequate size of the common
emoral arteries. Fourteen patients (51.9%) required cover-
ge of the left subclavian artery in order to cover the entry
ear or achieve a proximal seal and nine patients underwent
rophylactic revascularization with left carotid-subclavian
ypass. The celiac axis was partially covered in one patient
n order to cover a distal fenestration just proximal to the
isceral segment, and completely covered in one patient in
rder to obtain a seal distal to the aneurysmal true lumen.
Themean extent of thoracic aortic coverage was 22.1
.3 cm. Seventeen patients (63.0%) had stent graft cover-
ge from the left subclavian artery to the celiac axis; and 10
atients (25.9%) had coverage from the left subclavian
rtery to the mid-descending thoracic aorta. All 27 patients
able II. Patient demographics
haracteristic N (%)
ean age 67.5  9.6 yrs
en 18 (66.7%)
ypertension 27 (100%)
iabetes 3 (11.1%)
oronary artery disease 4 (14.8%)
OPD 7 (25.9%)
hronic renal insufficiency 3 (11.1%)
OPD, Chronic obstructive pulmonary disease.
hronic renal insufficiency defined as baseline creatinine 1.5.ad coverage of the proximal entry tear; no patient had
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operative angiogram. Two patients underwent nonelective
repair due to rupture (n1) and symptomatic aneurysm (n
1), respectively. One patient required intraoperative femoral-
femoral bypass because the left iliac artery arose from the false
lumen and all fenestrations were covered in the descending
thoracic aorta.
Procedural outcomes. Thirty-day mortality was 3.7%
(one of 27). In-hospital mortality was the same. The single
death occurred in the ruptured patient; therefore, 30-day
mortality in nonruptured patients was 0% (0 of 26). There
were three major complications (11.1%). Two patients
developed paraparesis (motor weakness in the lower ex-
tremities): one of whom had complete recovery of neuro-
logic function, and the other who improved but did not
recover completely. There was one access injury of an iliac
artery, which required stent graft placement. No patient
sustained stroke, paraplegia (complete loss of motor
strength), renal failure requiring new dialysis, or retrograde
acute type A aortic dissection after stent graft implantation.
Mean postoperative length of stay was 6.9  3.0 days. No
factor predicted 30-day mortality or major complication.
Midterm outcomes. Three-year survival in the 26
patients who survived to hospital discharge was 90.3% 
6.5% (Fig 2). No patient was lost to follow-up, and mean
duration of follow-up was 27.3 22.1months. There were
three late deaths due to unknown causes. No factor pre-
Fig 1. Demonstrates preoperative false lumen status on M2S
(West Lebanon, NH) imaging of patients with aneurysmal degen-
eration of chronic type B dissections. Preoperative false lumen
status was (A) patent in 18 patients and (B) partially thrombosed
in eight patients. One patient with a ruptured aneurysm had
unknown false lumen status.dicted decreased 3-year survival. pAll 26 patients who survived to hospital discharge had
ollow-up imaging, the mean duration of which was 18 
0 months. Of these 26 patients, 23 (88.5%) had throm-
osis of the aneurysmal false lumen. Of the 23 patients who
ventually had false lumen thrombosis, two patients had
ersistent perfusion of the aneurysmal false lumen through
he left subclavian artery and were successfully treated with
oil embolization. The three patients (three of 26) who
ailed to thrombose the aneurysmal false lumens had retro-
rade perfusion of the false lumen; one of these patients
lso suffered aneurysmal enlargement.
Twenty-two of the 26 patients (84.6%) who survived to
ospital discharge had shrinkage or stability of the aneurys-
al false lumen: 14 exhibited stability and 8 demonstrated
hrinkage. Of the four patients who had growth of their
neurysms, one had radiographic evidence of aneurysmal
alse lumen perfusion. No factor predicted aneurysmal false
umen thrombosis or aneurysm growth. Follow-up out-
omes by preoperative false lumen status are presented in
able III.
ISCUSSION
This experience with the treatment of chronic type B
issections with aneurysmal degeneration using TEVAR
eflects an evolution in the operative therapy of the disease.
he overall 90% 3-year survival in patients leaving the
perating room compares well both to patients treated
edically for type B dissection and to the results of open
epair for aneurysmal type B dissections.
The intermediate outcomes achieved with TEVAR of
hronic type B dissections with aneurysmal degeneration
ompare favorably with the results of medical management.
sai et al12 examined 201 patients with acute type B aortic
issections who survived to hospital discharge and found a
-year mortality rate of 24.9%; in particular, patients with
artially thrombosed false lumens fared the worst with a
-year mortality of 31.6%. Further subanalysis of the 146
ig 2. Kaplan-Meier survival for patients who underwent tho-
acic endovascular aneurysm repair (TEVAR) for aneurysmal de-
eneration of chronic type B dissections.atients who did not receive surgery or endovascular ther-
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false lumen was a significant predictor of postdischarge
mortality. Given the sobering outcomes of patients with
chronic type B dissections, the Investigation of Stent Grafts
in Aortic Dissection (INSTEAD) trial13 randomized pa-
tients with uncomplicated chronic type B dissections to
optimal medical management or elective stent graft place-
ment plus optimal medical management. Two-year survival
in the optimal medical therapy group was 95.6%, and in the
stent graft group it was 88.9%.
Before the introduction of thoracic stent graft devices,
the only option for repair was open thoracoabdominal
surgery of extent I or II thoracoabdominal aortic aneu-
rysms. The morbidity and mortality rates in these open
surgeries are not insignificant. In a large series of 104
patients with chronic distal aortic dissection who under-
went surgical repair, Zoli et al7 reported spinal cord injury
and stroke rates of 5%, and 30-day and 1-year mortality
rates of 10% and 22%, respectively. In another series of 148
patients with DTA aneurysms, in whom half had aneurysms
due to chronic DTA dissections, the spinal cord ischemia
rate was 3% and the 30-day mortality rate was 9%.8
Although there are few series of TEVAR for aneurysmal
degeneration of chronic type B dissections reported in the
literature, intermediate outcomes demonstrate favorable
results. Parsa et al5 assessed TEVAR for the management of
aneurysms related to chronic type B dissection in 51 pa-
tients and reported no strokes, permanent spinal cord inju-
ries, or in-hospital deaths; 5-year survival in this study was
78%. Meanwhile, Rodriguez et al11 examined the use of
stent grafts to treat 106 patients with acute and chronic
DTA dissections at the Arizona Heart Institute and re-
ported a spinal cord injury rate of 4% and a 30-day mortality
rate of 8%. The Arizona authors found that chronic dissec-
tions limited to the thoracic aorta were more likely to
undergo false lumen thrombosis. Last, Czerny et al15 ex-
amined the results of TEVAR in 14 patients with aneurysms
involving the descending aorta originating from chronic
type B dissections: two patients (14%) had type 1 proximal
endoleaks at early follow-up; however, the authors did not
provide rigorous survival statistics.
A Chinese group recently reported on 84 patients
undergoing TEVAR for chronic type B dissection,16 but
Table III. Outcomes following TEVAR for aneurysmal d
by preoperative false lumen status (n  26)
Outcome
Patient (n
Extent IIIa
(n  6)
Aneurysm sac thrombosis 6 (100%)
Aneurysm sac stability or shrinkage 4 (66.7%)
3-yr survival 75%
TEVAR, Thoracic endovascular aneurysm repair.they did not report the indication for repair in their cohort, lnd their practice is “to treat all patients with chronic type
dissection with a patent false lumen.” That practice is in
tark contrast to ours, which is to treat only symptomatic or
neurysmal type B dissections. With regard to reinterven-
ion in particular, Manning et al17 reported that six of 10
atients having undergone TEVAR for chronic type B
issection with false lumen aneurysms required reoperation
most often distal extension of stent grafts) at a mean
ollow-up (all patients) of 56 months. Our experience
ompares favorably to that one: two patients (7.4%) re-
uired subsequent adjunctive endovascular procedures to
reat type 2 endoleaks (both from patent left subclavian
rteries).
The approach to aneurysmal degeneration of chronic
ype B dissections in this series includes coverage of the
roximal entry tear and of all distal fenestrations within the
escending thoracic aorta. More distal fenestrations were
ot addressed, and the results of this series justify observa-
ion of the patent false lumen in cases of continued nonan-
urysmal false lumen perfusion. In cases of planned left
ubclavian coverage, patients underwent prior carotid-to-
ubclavian bypass and then coil embolization of the proxi-
al left subclavian at the time of TEVAR.18
Based on the current experience and prior clinical and
nvestigational studies, the authors feel that coverage of the
roximal entry tear is mandatory and often sufficient in
ases of chronic type B dissection with aneurysmal degen-
ration in order to achieve thrombosis of the aneurysmal
alse lumen. This agrees with the results and recommenda-
ions of Rodriguez et al11 in their study of TEVAR for acute
nd chronic type B dissection. In the current series, cover-
ge of the proximal entry tear required coverage of the left
ubclavian 51.9% of the time.
Parsa et al5 evaluated the retrograde pressurization of
he false lumen via distal fenestrations after stent graft
lacement by placing pressure measurement systems in the
alse lumen at the time of surgery, and found that the ratio
f false lumen aneurysm sac pressure to systemic arterial
ressure decreased, suggesting that persistent retrograde
alse lumen perfusion is clinically insignificant. Meanwhile,
armonik et al19 performed computational fluid dynamics
sing magnetic resonance images of a patient with an
xtent III Debakey dissection, and found that the false
eration of chronic descending thoracic aortic dissections
Preoperative false lumen status
)
Partially thrombosed
(n  8)
All patients
(n  26)
xtent IIIb
(n  12)
0 (83.3%) 7 (87.5%) 23 (88.5%)
2 (100%) 6 (75.0%) 22 (84.6%)
89% 100% 90%egen
 18
E
1
1umen pressure decreased essentially to zero with coverage
11
1
1
1
1
1
1
1
1
2
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 4 Nathan et al 967of the proximal entry tear only. Finally, Tsai et al20 exam-
ined the impact of tear location on false lumen pressure in
an ex vivo model of chronic type B aortic dissections with
an entry and exit tear, and reported that proximal entry tear
coverage resulted in a significant decrease in false lumen
pressurization.
While the INSTEAD trial13 failed to detect a benefit to
prophylactic TEVAR in chronic type B aortic dissection,
the current results, along with those of Parsa et al5 and
Rodriguez et al,11 provide compelling support for the use
of TEVAR to treat aneurysmal degeneration of chronic
type B dissections to prevent rupture. Given that four of 26
patients in this cohort suffered enlargement of their aneu-
rysm sacs, and that three of 26 patients had continued
perfusion of their aneurysmal false lumens, serial imaging at
regular intervals is essential in the follow-up of patients with
aneurysms treated with TEVAR.
CONCLUSIONS
TEVAR for aneurysms due to chronic dissections of the
DTA can be performed safely and effectively, as assessed at
midterm follow-up. Our approach involves mandatory cov-
erage of the proximal entry tear. Although this is a small
single-institution study, patients presenting with partially
thrombosed false lumens may benefit disproportionately
from endovascular repair, given their increased dissection-
related mortality relative to other anatomies.
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